We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksShearwater Regulatory News (SWG)

Share Price Information for Shearwater (SWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.00
Bid: 43.00
Ask: 45.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.651%)
Open: 44.00
High: 44.00
Low: 44.00
Prev. Close: 44.00
SWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options and Director/PDMR Dealing

11 Feb 2022 07:00

RNS Number : 3655B
Shearwater Group PLC
11 February 2022
 

11 February 2022

Shearwater Group PLC("Shearwater" or the "Group")

Grant of Options and Director/PDMR Dealing

 

Shearwater Group plc (AIM: SWG), the organisational resilience group that provides cybersecurity, advisory and managed security services, announces the grant of options to acquire, in aggregate, up to 668,110 ordinary shares of 10 pence each (the "Options") to a broad range of the Group's employees. The Options have been granted to ensure that the Group's employees are well motivated and identify closely with the success of the Group.

 

Options to acquire up to 640,714 shares have been granted under the newly-adopted Shearwater Group Company Share Option Plan (the "CSOP") and Options to acquire up to 27,396 shares have been granted under the existing Shearwater Group Employee Share Option Plan (the "ESOP"). Options granted under the CSOP are intended to benefit from tax reliefs, whereas Options granted under the ESOP do not qualify for these reliefs.

 

The Options will be exercisable from vesting until the fifth anniversary of grant at a price of £0.95 per new ordinary share, a price equal to the closing mid-market price per Shearwater ordinary share on 9 February 2022.

 

Subject to the satisfaction of performance conditions and continued employment, where applicable, the Options will vest as to 89,998 shares on the first anniversary of grant, 11,112 shares on 10 September 2023 and 567,000 shares on the third anniversary of grant.

An Option over 25,000 shares has been granted under the CSOP to Paul McFadden, the Group's Chief Financial Officer and the notification below, made in accordance with the UK Market Abuse Regulation, provides further details in this regard.

 

Director

Position

Number of shares under option

Exercise price

Vesting date*

Expiry date

Paul McFadden

CFO

25,000

 

£0.95

 

10 February 2025

 

10 February 2027

 

*subject to the satisfaction of performance conditions

 

Following the grant of the Options, the Group has options outstanding over a total of 909,862 shares, which represent approximately 3.9% of the Company's existing issued ordinary share capital.

 

Enquiries:

Shearwater Group plc

David Williams

Phil Higgins

 

www.shearwatergroup.com

c/o Alma PR

Cenkos Securities plc - NOMAD and Joint Broker

Ben Jeynes / Max Gould - Corporate Finance

Julian Morse / Michael Johnson - Sales

 

+44 (0) 20 7397 8900

Berenberg - Joint Broker

Matthew Armitt / Mark Whitmore

 

+44 (0) 20 3207 7800

Alma PR

Susie Hudson / Caroline Forde / Joe Pederzolli

shearwater@almapr.co.uk 

+44 (0) 20 3405 0205

 

 

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul McFadden

 

2

Reason for the notification

a)

Position/status

Chief Financial Officer

 

b)

Initial notification /Amendment

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Shearwater Group plc

 

b)

LEI

213800ZRUKUYDJLKD504

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BKT6VH21

 

b)

Nature of the transaction

Grant of share option under the Shearwater Group Company Share Option Plan

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

nil

 25,000

d)

Aggregated information

- Aggregated volume

- Price

 

 N/A - single transaction

e)

Date of the transaction

10 February 2022

 

f)

Place of the transaction

Outside of a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKKBDNBKBKBD
Date   Source Headline
3rd Apr 20247:00 amRNSFY24 Trading Update
4th Jan 20247:00 amRNSContract Wins
22nd Nov 20237:00 amRNSInterim Results
21st Nov 202311:18 amRNSChange of Nominated Adviser and Broker
20th Nov 20231:19 pmRNSBoard Update
3rd Nov 202310:12 amRNSNotice of Results and Board Appointment
10th Oct 20237:00 amRNSInterim CFO Appointment
5th Sep 20237:00 amRNSFinal Results
25th Aug 20237:00 amRNSUpdate re FY23 Results and Trading Update
8th Jun 20237:00 amRNSTrading Update
5th May 20232:33 pmRNSHolding(s) in Company
18th Apr 20238:58 amRNSDirector/PDMR Shareholding
17th Apr 202312:51 pmRNSDirector/PDMR Shareholding
6th Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20232:05 pmRNSSecond Price Monitoring Extn
31st Mar 20232:00 pmRNSPrice Monitoring Extension
31st Mar 20239:05 amRNSSecond Price Monitoring Extn
31st Mar 20239:00 amRNSPrice Monitoring Extension
31st Mar 20237:00 amRNSTrading Update
8th Mar 20233:30 pmRNSHolding(s) in Company
28th Feb 20231:26 pmRNSExercise of Options
8th Dec 20222:34 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector/PDMR Shareholding
1st Dec 20222:40 pmRNSDirector/PDMR Shareholding
29th Nov 20222:05 pmRNSSecond Price Monitoring Extn
29th Nov 20222:00 pmRNSPrice Monitoring Extension
29th Nov 20227:00 amRNSResults for the six months ended 30 September 2022
23rd Nov 20227:00 amRNSAdviser Update
17th Nov 20227:00 amRNSNotice of Results and Presentation to Investors
7th Oct 20228:32 amRNSHolding(s) in Company
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
21st Sep 20227:00 amRNSResult of AGM
5th Sep 202210:00 amRNSNotice of AGM
1st Sep 20227:00 amRNSContract Renewal
25th Aug 20227:00 amRNSPosting of Annual Report
23rd Aug 20222:43 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSFinal Results
22nd Jul 20227:00 amRNSNotice of Results and Presentation to Investors
6th Jun 20224:41 pmRNSSecond Price Monitoring Extn
6th Jun 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20227:00 amRNSYear End Trading Update
13th Apr 20227:00 amRNSContract Win
24th Mar 20227:00 amRNSContract Win
22nd Mar 20224:37 pmRNSExercise of options
17th Mar 20227:00 amRNSContract Win
3rd Mar 20224:26 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSGrant of Options and Director/PDMR Dealing
27th Jan 20227:00 amRNSContract Renewals
11th Jan 20227:00 amRNSContract Win
14th Dec 20217:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.